Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Pre-tax earnings
Latest
$-155.22M
↓ 41% vs avg
Percentile
P18
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-110.40M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-155.22M | +25.4% |
| 2024 | $-207.97M | +38.6% |
| 2023 | $-338.82M | -303.6% |
| 2022 | $-83.95M | -27.9% |
| 2021 | $-65.66M | +18.8% |
| 2020 | $-80.89M | -3.4% |
| 2019 | $-78.25M | -76.5% |
| 2018 | $-44.35M | -62.8% |
| 2017 | $-27.24M | -25.5% |
| 2016 | $-21.70M | - |